HANGZHOU AGS MEDTECH CO., LTD. Hangzhou AGS MedTech Co., Ltd. Stock
Equities
688581
CNE100005ZF0
Advanced Medical Equipment & Technology
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 76.48 CNY | -0.84% |
|
-4.59% | -38.72% |
| Sales 2024 * | 666M 91.86M | Sales 2025 * | 881M 122M | Capitalization | 4.41B 608M |
|---|---|---|---|---|---|
| Net income 2024 * | 271M 37.39M | Net income 2025 * | 347M 47.88M | EV / Sales 2024 * | 6.62 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 5 x |
| P/E ratio 2024 * |
17.4
x | P/E ratio 2025 * |
12.8
x | Employees | 592 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 22.98% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.84% | ||
| 1 week | -4.59% | ||
| Current month | -4.59% | ||
| 1 month | -8.95% | ||
| 3 months | -2.19% | ||
| 6 months | -34.69% | ||
| Current year | -38.72% |
1 week
75.70
82.30
1 month
75.7082.79
Current year
60.09128.47
1 year
60.09132.78
3 years
60.09137.60
5 years
60.09137.60
10 years
60.09137.60
| Managers | Title | Age | Since |
|---|---|---|---|
Cheng Zhang
CEO | Chief Executive Officer | 54 | 11-11-30 |
Jun Can Chen
DFI | Director of Finance/CFO | 43 | 17-12-31 |
Bai Ming Shi
CHM | Chairman | 45 | 11-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Jian Hai Wu
BRD | Director/Board Member | 44 | 19-05-28 |
Li An Xia
BRD | Director/Board Member | 60 | 19-05-28 |
Cheng Zhang
CEO | Chief Executive Officer | 54 | 11-11-30 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-06-07 | 76.48 | -0.84% | 486,380 |
| 24-06-06 | 77.13 | -3.35% | 667,459 |
| 24-06-05 | 79.8 | -1.80% | 496,933 |
| 24-06-04 | 81.26 | +2.36% | 465,694 |
| 24-06-03 | 79.39 | -0.96% | 542,687 |
End-of-day quote Shanghai S.E., June 06, 2024
More quotes
Hangzhou AGS MedTech Co Ltd is a China-based company mainly engaged in the research, development, production and sales of endoscopic minimally invasive diagnostic and therapeutic devices. The Company's main products are used in the field of digestive endoscopy diagnosis and treatment, and are divided into hemostatic closure, EMR/ESD, biopsy, ERCP and diagnosis and treatment instruments according to their therapeutic purposes. The hemostatic closure category includes clip devices and single-use bipolar high-frequency hemostats. Medical instruments include high-frequency surgical equipment, carbon dioxide gas supply devices for endoscopes, and water supply devices for endoscopes. The biopsy category includes single-use biopsy forceps and single-use graspers.
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
76.48
CNY
Average target price
122.5
CNY
Spread / Average Target
+60.17%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -38.72% | 608M | |
| +9.48% | 222B | |
| +13.72% | 195B | |
| +23.79% | 148B | |
| +33.39% | 113B | |
| +3.80% | 66.45B | |
| +15.59% | 53.11B | |
| +3.16% | 50.03B | |
| -4.35% | 38.8B | |
| -1.27% | 34.85B |
- Stock Market
- Equities
- 688581 Stock
